In the vasculature, nitric oxide (NO) is generated by endothelial NO synthase (eNOS) in a calcium/calmodulin-dependent reaction. With oxidative stress, the critical cofactor BH 4 is depleted, and NADPH oxidation is uncoupled from NO generation, leading to production of (O 2 . . generation from the enzyme at low Ca 2؉ concentrations, and PKC␣-mediated phosphorylation alters the sensitivity of the enzyme to other negative regulatory signals.
with the consumption of NADPH. NO is a signaling molecule that promotes vascular smooth muscle relaxation and functions as an endogenous mediator of a wide range of effects in different tissues (1, 2) . After oxidant stress, as occurs in postischemic tissues, production of O 2 . and its derived oxidants, including peroxynitrite (ONOO Ϫ ), hydrogen peroxide (H 2 O 2 ), and hydroxyl radical (⅐OH), induce NOS dysfunction with uncoupling of the enzyme leading to the production of NOSderived O 2 . instead of NO (3, 4) . It has been reported that an imbalance between NO and O 2 . can contribute to the onset of a variety of cardiovascular diseases, including hypertension, atherosclerosis, and heart failure (5). Therefore, tight coupling of the enzyme is important for normal cardiovascular function and prevention of disease. The catalytic domains of NOS include a flavin-containing NADPH binding reductase and a heme-binding oxygenase that also contains the binding sites for the redox labile cofactor tetrahydrobiopterin (BH 4 ) and the substrate L-Arg. In the presence of Ca 2ϩ and calmodulin (CaM), electrons flow from NADPH through the reductase domain to the oxygenase domain resulting in the activation of oxygen at the heme center followed by substrate monooxygenation. This process requires the presence of the fully reduced BH 4 . Our laboratory and several others have demonstrated that besides synthesizing NO, all three isoforms of NOS can also generate O 2 . , depending on substrate and cofactor availability (3, 6 -9) . One of the primary mechanisms implicated in the oxidant-induced switch of NOS from the production of NO to the generation of O 2 . is the oxidation of the enzyme bound BH 4 (10, 11) . Various extracellular signals, including shear stress and additional stimuli such as vascular endothelial growth factor (VEGF), estrogen, sphingosine 1-phosphate, bradykinin, and aldosterone, modulate eNOS NO generation through several signal transduction pathways (12) (13) (14) (15) (16) . Cellular studies have demonstrated that phosphorylation of eNOS at specific amino acids regulates enzyme-mediated NO production (17) . The majority of previous work has focused on two residues, serine 1177 and threonine 495. It has been shown that Akt specifically induces phosphorylation of Ser-1177 (18, 19) and that PKC specifically phosphorylates Thr-495 (20) . Although phosphorylation of Ser-1177 has been shown to increase NO production from eNOS (21) , in contrast, phosphorylation of Thr-495 has been reported to down-regulate NO generation (18, 22, 23) .
Although there is strong evidence indicating that phosphorylation of eNOS is involved in directly modulating eNOS-mediated NO generation, the definitive mechanisms involved remain unclear. Moreover, there is a lack of prior investigation directed toward understanding how phosphorylation alters O 2 . generation from the uncoupled enzyme. Determination of the effects of phosphorylation on eNOS-derived O 2 . generation is of particular importance, because of the implications of this regulation in cardiovascular disease and other physiological settings in which eNOS is uncoupled (3, 4) . Delineation of the mechanisms involved in the phosphorylation-dependent regulation of uncoupled eNOS will provide critical insights regarding the pathophysiology of eNOS dysfunction. Therefore, studies were performed to investigate how phosphorylation by the critical signaling kinases Akt or PKC␣ modulates eNOS uncoupling and the production of O 2 . from the enzyme. Studies were performed with in vitro phosphorylation of recombinant human eNOS and also with intact endothelial cells. Our results demonstrated that phosphorylation of eNOS at Ser-1177 is pivotal in the regulation of O 2 . generation, altering both the Ca 2ϩ sensitivity of the enzyme and maximal rate of product generation, whereas phosphorylation of Thr-495 indirectly affects O 2 . generation by modulating the binding of proteins known to regulate the activity of the enzyme.
EXPERIMENTAL PROCEDURES
Materials-Akt1 kinase, PKC␣ kinase, anti-eNOS antibody, anti-phospho-Ser-1177, and anti-phospho-Thr-495 eNOS antibodies were purchased from Cell Signaling Technology, Inc. (Danvers, MA). Terrific broth, LB broth base, EZQ phosphoprotein quantification kit, dithiothreitol (DTT), and carbenicillin were obtained from Invitrogen. Protease inhibitor mixture tablets were purchased from Roche. NADPH, L-Arg, and hemoglobin were purchased from Sigma-Aldrich. Isopropyl ␤-D-1-thiogalactopyranoside was purchased from Anatrace, Inc. (Maumee, OH). Chloramphenicol was obtained from Fluka (St. Louis, MO). 5-Diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide (DEPMPO) was purchased from Alexis Biochemicals (San Diego, CA). Caveolin peptide (Cav-P) was custom-synthesized by Bio-Synthesis Inc. (Lewisville, TX). The sequence of Cav-P is DGIWKASFTTFTVTKYWFYR (24) .
Protein Expression and Purification-The bacterial expression plasmid of pCWheNOS was a gift from Dr. Ortiz de Montellano from University of California at San Franscisco. Overexpression of active human eNOS in Escherichia coli was greatly enhanced by coexpression with calmodulin (pCaM). Typically, a 10-ml LB overnight culture of pCWheNOS and pCaM in BL21(DE3) E. coli was used to inoculate 1 liter of terrific broth in a 4-liter flask containing 125 g/ml carbenicillin and 50 g/ml chloramphenicol. The culture was grown at 37°C until the cell density reached an A 600 of 0.8, then ␦-aminolevulinic acid was added to a final concentration of 0.5 mM, and the cells were induced by the addition of isopropyl ␤-D-1-thiogalactopyranoside (1 mM final concentration). The cultures were then grown at 22°C at 200 rpm for 20 h before harvest by centrifugation at 4°C. The cell pellet was stored at Ϫ80°C until purification (25, 26) .
Typically, 2 liters of human eNOS (heNOS)-expressing cells were pelleted and resuspended in 50 ml of lysis buffer containing 40 mM HEPES, pH 7.6, 10% glycerol, 500 mM NaCl, 40 mM imidazole, 1 mM DTT, 10 M BH 4 , and 5 tablets of protease inhibitor mixture, EDTA free. The cells were lysed in the presence of 20 mg/ml lysozyme on ice for 30 min with stirring by pulse sonication 10 s each cycle with a total of ϳ15 cycles. During the sonication the solution was always kept below 4°C to prevent any degradation or inactivation of the enzyme. The cell debris was cleared by centrifugation at 48,000 ϫ g for 1 h at 4°C. The supernatant was applied to a 5-ml HisTrap nickelnitrilotriacetic acid column (GE Healthcare) equilibrated with lysis buffer using an AKTA fast protein liquid chromatography system (GE Healthcare). The column was then washed with 10 column volumes of buffer A (40 mM HEPES, pH 7.6, 10% glycerol, 40 mM imidazole, 1 mM DTT, 10 M BH 4 ). Finally the heNOS was eluted with buffer B (40 mM HEPES, pH 7.6, 10% glycerol, 500 mM NaCl, 250 mM imidazole, 1 mM DTT, 10 M BH 4 ). The colored fractions were pooled, and 20 mM L-Arg, 20 M BH 4 , and 5 mM DTT were added and incubated on ice for 4 h. The purified protein was subsequently loaded into Hi-Load Superdex 200 size exclusion column equilibrated with buffer C (40 mM HEPES, pH 7.6, 10% glycerol, 150 mM NaCl, 1 mM DTT). The colored fractions were pooled and concentrated to greater than 1 mg/ml by ultrafiltration. The concentrated protein was separated into aliquots and quickly frozen in liquid nitrogen before storage at Ϫ80°C. When heNOS was coexpressed with CaM, 2 mM CaCl 2 was included in all purification buffers (26) . Because of the instability of purified heNOS, the entire purification process was completed within 1 day. For the BH 4 -free heNOS, used for O 2 . determinations, L-Arg and BH 4 were excluded during the purification process. To remove CaM from the heNOS purification, 2 mM EGTA was included in Buffer C. Phosphorylation of heNOS by Akt and PKC␣-heNOS (5 M, 0.675 g/l) was phosphorylated at RT for 20 min with Akt or PKC␣ (100 ng) in a total volume of 20 l in 1ϫ kinase buffer containing 25 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 5 mM ␤-glycerophosphate, 0.1 mM Na 3 VO 4 , 2 mM DTT, 200 M ATP according to manufacturer's protocol. After phosphorylation, the phosphorylated heNOS was subjected to immunoblotting analysis or EZQ phosphoprotein determination. The Invitrogen EZQ phosphoprotein quantification kit was used to determine the phosphorylation efficiency of heNOS by Akt and PKC␣. According to the procedures in the manufacture's manual, the phosphorylated heNOS by Akt, PKC␣, or both was spotted onto specially prepared assay paper, fixed onto the paper with methanol, and then stained with EZQ phosphoprotein quantification reagent. The dried assay paper was inserted onto EZQ 96-well microplate cassette, and the stained protein spots were analyzed in a fluorescence-based reader (SpectraMax GEMINIXS, Molecular Devices, Sunnyvale, CA) using excitation/emission wavelengths of 550/580 nm. Relative phosphate content of phosphorylated heNOS was determined from a standard curve of ovalbumin, which contains two phosphate groups per molecule. The control experiments with kinase alone were always performed, and the fluorescent intensity of control experiments was subtracted from all experiments.
Protein and Heme Content Determination-Protein concentration of purified heNOS was determined by the Bradford assay from Bio-Rad using a bovine serum albumin standard. The heme content of the purified heNOS was determined by pyridine hemochromogen assay. 50 g of heNOS was added to a solution containing 0.15 M NaOH and 1.8 M pyridine, and the difference spectrum (reduced minus oxidized bispyridine heme) was recorded using ⌬⑀ ϭ 24 mM Ϫ1 cm Ϫ1 at 556 -538 nm (27) . The reduced bispyridine heme was generated by the addition of a few grains of dithionite.
SDS-PAGE and Immunoblotting-The reaction mixture was mixed with the sample loading buffer at a ratio 3:1 (v/v), incubated at 80°C for 10 min, and then immediately loaded onto a 4 -20% Tris-glycine polyacrylamide gradient gel. Samples were run at room temperature for 1.5 h at 125 V. Protein bands were electrophoretically transferred to a nitrocellulose membrane in 12 mM Tris, 96 mM glycine, and 20% methanol with a Xcell II Blot Module from Invitrogen with 25 V constant for 90 min. Membranes were blocked for 1 h at room temperature in Trisbuffered saline (TBS) containing 0.05% Tween 20 (TBST) with 5% dry milk (Bio-Rad). Membranes were then incubated overnight with anti-eNOS, anti-phospho-Thr-495, or anti-phospho-Ser-1177 eNOS polyclonal antibodies at 4°C. Membranes were then washed 3 times in TBST and incubated for 1 h with horseradish peroxidase-conjugated anti-rabbit IgG in TBST at room temperature. Membranes were again washed three times in TBST and then visualized using ECL immunoblotting detection reagents (Amersham Biosciences). The signal intensity of blotting was digitized and quantified using an AlphaImager TM high performance gel documentation and image analysis system, model 3300 (Alpha Innotech Co. San Leandro, CA).
Measurement of O 2 . Generation by EPR Spin Trapping-
Spin-trapping measurements of oxygen radicals were performed in 50 mM Tris-HCl buffer, pH 7.4, containing 0.5 mM NADPH, 0.5 mM Ca 2ϩ , 10 g/ml CaM, 15 g/ml purified heNOS, and 25 mM spin trap DEPMPO. EPR spectra were recorded in a 50-l capillary at room temperature with a Bruker EMX spectrometer operating at 9.86 GHz with 100 kHz modulation frequency as described (28, 29) . The sample was scanned using the following parameters: center field, 3510 G; sweep width, 140 G; power, 20 milliwatts; receiver gain, 2 ϫ 10 5 ; modulation amplitude, 1 G; time of conversion, 41 ms; time constant, 328 ms.
Generation from heNOS-100 l of reaction volume was typically used for EPR measurements containing 100 M EGTA. The reaction was initiated by the addition of 0.5 mM NADPH. The O 2 . measurements were performed by EPR spin-trapping as described above. The free Ca 2ϩ concentration in the Ca 2ϩ dependence studies was calculated using winmaxc32 program version 2.5 (Stanford University) (30, 31) accounting for pH and buffer components of phosphorylation reactions and 100 M EGTA.
Cav-P Inhibition of O 2 . Generation from heNOS-A 100-l reaction volume was typically used for EPR measurements, identical to that described above except that Cav-P (400 M final concentration) was added to each reaction. The reaction was initiated by the addition of 0.5 mM NADPH. The O 2 . measurements were performed and quantified by EPR spin-trapping as described above.
Measurement of O 2 . from Uncoupled eNOS in Endothelial
Cells-Bovine aortic endothelial cells (BAECs) cultured on sterile coverslips (Harvard Apparatus, 22 mm 2 ) in 35-mm sterile dishes at a density of 10 4 cells/dish were subjected to BH 4 depletion. To deplete BH 4 , BAECs were treated with 5 mM 2,4-diamino-6-hydroxypyrimidine, an inhibitor of GTPCH1 (GTPcyclohydrolase I) involved in BH 4 biosynthesis, for 18 h (32). For VEGF treatment (22) , a final concentration of 50 ng/ml VEGF was added to BAECs or 2,4-diamino-6-hydroxypyrimidine-treated BAECs for 10 min to activate Ser-1179 phosphorylation of bovine eNOS (beNOS). Ionomycin (calcium ionophore (CaI)) (22) . Nuclei were stained with blue fluorescent DAPI (1 M) for 10 min in the incubator. After the incubation, cells were washed with 1ϫ phosphate-buffered saline and mounted using a mounting medium Fluoromount-G, and images were captured and analyzed at a magnification of 20ϫ for DHE and DAPI by confocal fluorescence microscopy (LSM 510; Zeiss Inc., Peabody, MA) and overlaid using LSM software.
Immunofluorescence Microscopy-BAECs cultured on sterile coverslips (Harvard Apparatus, 22 mm 2 ) in 35-mm sterile dishes at a density of 10 4 cells/dish were subjected to BH 4 depletion and Ser-1179 and Thr-497 phosphorylation, as described in the previous section. At the end of the experiment, cells attached to coverslips were washed with 1ϫ phosphate-buffered saline and fixed with 3.7% paraformaldehyde for 10 min, permeabilized with 0.25% Triton X-100 in TBST containing 0.01% Tween 20 for 5 min, and blocked for 30 min with 1% bovine serum albumin in 0.01% TBST. For visualization of beNOS Ser-1179 and Thr-497 phosphorylation, the fixed and permeabilized cells were incubated with rabbit primary antiphospho-Ser-1179 and anti-phospho-Thr-497 eNOS antibodies, respectively, at a dilution of 1:2000 in 0.01% TBST containing 1% bovine serum albumin for 1 h at room temperature followed by an anti-rabbit AlexaFluor 488-conjugated antibody (1:1000 dilution) for 1 h at room temperature. The coverslips with cells were then mounted on a glass slide with the antifade mounting medium and viewed with a Zeiss confocal microscope at a magnification of 60ϫ, and images were captured digitally.
RESULTS
Protein Expression, Purification, and Characterization-To mitigate problems with low yield and instability of heNOS when expressed in an E. coli system, recombinant human eNOS was coexpressed with CaM as reported previously (26) and iso-lated using nickel-nitrilotriacetic acid affinity and size exclusion chromatography. The coexpression of heNOS with CaM increased the yield 3-fold compared with expression of heNOS alone (3 mg/liter versus 1 mg/liter), consistent with previous reports (26) . The purified protein preparations exhibited one prominent band (Ͼ95% pure) on 4 -20% SDS-PAGE with Coomassie staining. The molecular weight of the purified protein, 135 kDa, is in accordance with the molecular mass for native heNOS monomer (3, 10, 33) , and the identity of this band was confirmed by immunoblotting using an anti-eNOS antibody (Fig. 1) , and mass spectrometry (data not shown). The NO generation, as determined by monitoring the conversion of oxyhemoglobin to ferric methemoglobin from the recombinant protein, was consistent with reported values (100 -140 nmol⅐min Ϫ1 ⅐mg Ϫ1 ) (3, 26) , and as expected the catalytic activity was dependent upon the addition of Ca 2ϩ and CaM and could be totally blocked by the NOS inhibitor, L-NAME (1 mM).
Phosphorylation of heNOS by Akt and PKC␣-Purified recombinant heNOS was phosphorylated at Ser-1177, Thr-495, or at both sites using the kinases Akt and PKC␣ in the presence of 1ϫ kinase buffer at RT. The reactions reached completion by 20 min for both Akt and PKC␣ based on Akt phosphorylation time course immunoblotting. The phosphorylation events were confirmed by immunoblotting with anti-phospho-Ser-1177 and anti-phospho-Thr-495 antibodies (Fig. 1) . These results indicated that Akt specifically phosphorylated heNOS at Ser-1177, whereas PKC␣ phosphorylation was specific for Thr-495. Additionally, equivalent phosphorylation of both sites occurs when using both Akt and PKC␣. The extent of phosphorylation of heNOS at each site was determined by EZQ phosphoprotein quantitation kit. The phosphorylation of heNOS at Ser-1177 by Akt was determined to be ϳ80%, and the phosphorylation of Thr-495 by PKC␣ was determined to be close to 100% (34 . production, this 10-l reaction mixture was diluted into a total volume of 100 l containing only Ca 2ϩ /CaM, and the reaction was initiated by the addition of NADPH to a final concentration of 0.5 mM. EPR measurements were carried out, as described under "Experimental Procedures," with the nitrone spin trap DEPMPO, which forms a stable O 2 . adduct with a half-life of ϳ16 min (28).
Kinetics of O 2 . generation from heNOS were determined by setting the static field at ϳ3501.1 G, on the maximum of the fourth peak of the EPR spectrum of the DEPMPO/⅐OOH spin trap adduct (Fig. 2A) . The reaction rate of O 2 . generation was . generation from control and phospho-Ser-1177 heNOS was measured by fixing the static field at 3501.1 G on the maximum of the 4th peak of the DEPMPO-OOH adduct, as marked by the asterisk. The time constant was 5243 ms. The reaction system and acquisition parameters were otherwise the same as in A.
determined by a linear fitting of this signal amplitude change versus time during the first 5 min of reaction (Fig. 2B) . generation even in the absence of free Ca 2ϩ . The NOS inhibitor L-NAME, which is known to inhibit both NO and O 2 . generation from eNOS, was able to almost totally block O 2 . production from the phosphorylated enzyme over the full range of Ca 2ϩ concentrations studied. PKC␣ phosphorylation, however, only slightly altered the Ca 2ϩ -dependent activation of O 2 . generation compared with that of non-phosphorylated heNOS (23.2 versus 22.1 M) ( Fig. 4 ; Table 1 ).
EGTA Inactivation of O 2 . Generation from heNOS-In these
experiments the active eNOS⅐CaM⅐Ca 2ϩ complex was allowed to form, and then increasing concentrations of EGTA were added to chelate the Ca 2ϩ and initiate the dissociation of the complex. After 1 min, the rate of O 2 . generation was determined using EPR spin-trapping, as described above. At an EGTA concentration of 800 M, no O 2 . signal was detected from the nonphosphorylated enzyme; however, the phospho-Ser-1177 eNOS still retained ϳ40% of its maximal O 2 . generation capac- . generation rates from control and phosphorylated heNOS were determined from preparations of enzyme by EPR spin-trapping with DEPMPO as described in Fig. 2 . The phosphorylation of heNOS by Akt or Akt and PKC␣ increased its O 2 . generation by greater than 50%; however, there was no significant effect from the phosphorylation of heNOS by PKC␣. Data were expressed as the mean Ϯ S.E., n ϭ 3 (*, p Ͻ 0.001 versus control). . generation rates from control, phospho-Ser-1177, and phospho-Thr-495 heNOS were determined by EPR spin-trapping with DEPMPO as described in Fig. 2 . In the reaction 100 M EGTA was included in the assay buffer. The desired Ca 2ϩ concentration was achieved by the addition of a concentrated CaCl 2 stock solution. The free [Ca 2ϩ ] was calculated as described under "Experimental Procedures." O 2 . generation from eNOS was almost totally blocked by 1 mM L-NAME over the full range of Ca 2ϩ concentrations studied. All data points show the relative magnitude of O 2 . generation compared with the maximal values measured from control heNOS and correspond to the mean Ϯ S.E. from triplicate experiments. . , and phosphorylation of the enzyme did not lead to uncoupling. To uncouple eNOS, BAECs were first treated with 5 mM 2,4-diamino-6-hydroxypyrimidine for 18 h to deplete BH 4 (32) . In control BH 4 -depleted cells, there was no detectable red HE fluorescence (Fig. 7A) . Note, DAPI staining was used to counter stain the nuclei (blue). However, when the BH 4 -depleted BAECs were treated with either CaI, commonly used to induce Ca 2ϩ influx, or VEGF to induce Akt activation with phosphorylation of Ser-1179, strong red HE fluorescence was detected, and this stimulated O 2 . generation was completely inhibited by 1 mM L-NAME. This HE fluorescence was also completely quenched by the superoxide dismutase mimetic MnTBAP . generation rates from control and phosphoSer-1177 heNOS were determined by EPR spin-trapping with DEPMPO as described in Fig. 2 . The effect of phosphorylation of heNOS on the EGTA inactivation of O 2 . generation was determined. 200 M Ca 2ϩ was included in the reaction. In control experiments, when EGTA was added to a final concentration of 800 M, there is no measurable O 2 . generation, although with Akt phosphorylation, even with 1000 M EGTA, still ϳ25% of the O 2 . generation remained. All data points show the relative magnitude of O 2 . generation compared with the maximal values measured from control heNOS and correspond to the mean Ϯ S.E. from triplicate experiments. The line fitting of the experimental points for each curve was performed using a sigmoidal function. . generation rate from control, phospho-Ser-1177, and phospho-Thr-495 heNOS was determined from preparations of enzyme by EPR spin-trapping with DEPMPO as described in Fig. 2 . The effect of phosphorylation of heNOS on the interaction with CaM under uncoupled (BH 4 -free) conditions was determined. In the presence of 0.5 mM CaCl 2 , CaM was added to the desired concentration as indicated. The concentration of CaM required for 50% maximal activity of O 2 . generation (EC 50 ) was determined from CaM dependence of heNOS O 2 . generation. The EC 50 of control heNOS was 208 nM, the EC 50 of phospho-Ser-1177 heNOS was 149 nM, and the EC 50 of phospho-Thr-495 heNOS was 496 nM. Data were expressed as mean Ϯ S.E., n ϭ 3. (manganese (III) tetrakis (4-benzoic acid) porphyrin), 1 mM, confirming that it was derived from O 2 . (data not shown). Treatment of BH 4 -depleted BAECs with the PKC activator PMA, which increases intracellular Ca 2ϩ and induces phosphorylation of Thr-497 (38), was performed, and these cells also exhibited red HE fluorescence similar to that induced by CaI. The phosphorylation of beNOS produced by each stimulus was determined by immunofluorescence microscopy using phospho-specific eNOS antibodies (Fig. 7B) . Phosphorylation of uncoupled beNOS at Ser-1179 was seen when cells were treated with either VEGF or CaI, whereas treatment of BH 4 -depleted cells with PMA led to the phosphorylation of eNOS mainly on Thr-497. Therefore, the formation of O 2 . from uncoupled beNOS in endothelial cells is stimulated by phosphorylation of the uncoupled enzyme at Ser-1179 or Thr-497 . Moreover, just as in our isolated enzyme experiments, phosphorylation of Thr-497 did not inhibit the formation of eNOS-derived O 2 . .
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DISCUSSION
Nitric-oxide synthase requires BH 4 to produce NO from L-Arg in a reaction involving the NADPHdependent formation of a hemebound two-electron reduced molecular oxygen moiety. In the absence of BH 4 , NOS is unable to timely donate the second electron, resulting in O 2 . release from the heme center, thus uncoupling NADPH oxidation from NO formation. The switch from NO to O 2 . production that is triggered by oxidative depletion of BH 4 has been implicated in the pathophysiology of numerous diseases (11, 39 -43) . Therefore, it is of critical importance to understand how the production of both of these eNOS-derived products is regulated. Several sites have been identified in eNOS with the potential for phosphorylation and posttranslational regulation, including Ser-1177, Thr-495, and serines 114, 615, and 633 (using the human amino acid numbering). However, prior work has shown that modifications of Ser-1177 and Thr-495 are of particular importance. It is commonly accepted that eNOS NO production is inhibited by phosphorylation at Thr-495 and enhanced by phosphorylation at Ser-1177 (20, 22, 44, 45) . However, questions remain regarding the effect that phosphorylation of these two key residues has on the O 2 . production of the uncoupled enzyme.
Therefore, in this work we have used EPR spin-trapping to determine how phosphorylation of recombinant human eNOS by native kinases affects the O 2 . production of the BH 4 -free enzyme. We show that phosphorylation of Ser-1177 increased the rate of O 2 . generation by Ͼ50% in the presence of excess Ca 2ϩ /CaM, whereas phosphorylation of Thr-495 had no effect under these conditions.
Phosphorylation of eNOS at Ser-1177 for human or Ser-1179 for bovine was first demonstrated to regulate its NO production in 1999 by Fulton et al. (18) and separately by Dimmeler et al. (19) . It was shown that phosphorylation of this residue via the kinase Akt in cells leads to an increase in NOS-derived NO. Since then, isolated enzyme studies have shown that the S1177D eNOS mutant (mimicking the Ser-1177 phosphoryla- . generation was visualized from BH 4 -depleted BAECs loaded with DHE that reacts to form HE, that exhibits red fluorescence. The blue color corresponds to the nuclei stained with DAPI. Measurable O 2 . fluorescence was seen only when the BH 4 -depleted cells were treated with CaI, VEGF, or PMA, and this was inhibited by L-NAME. B, immunostaining using phosphorylation specific anti-eNOS antibodies in BH 4 -depleted BAECs. The left column shows the results using the anti-phospho-Ser-1179 antibody. Ser-1179 phosphorylation was detected in BH 4 -depleted BAECs when the cells were treated with CaI or VEGF but not with PMA. The right column shows the results using the anti-phospho-Thr-497 antibody, demonstrating that PMA treatment produced strong phosphorylation of Thr-497. These two immunostaining experiments were done in two sets of cells, both under the same conditions. ted eNOS) leads to an increase in the electron flow through the reductase domain, and it was hypothesized that this increase is the mechanism responsible for the phosphorylation-dependent increase in eNOS-derived NO (21) .
In . from the heme is the transfer of electrons from the reductase domain to the oxygenase domain (47, 48) , which in the global kinetic model of NOS activity proposed by Stuehr et al. (49) is the same rate-limiting step for NO production. Thus, it would be expected that any modification that alters eNOS NO production will similarly alter the activity of the uncoupled enzyme. Indeed, Ser-1177 phosphorylation increased the O 2 . production from the enzyme switching eNOS from Ca 2ϩ -dependent to more Ca 2ϩ -independent O 2 . generation, more like NOS-2. The EC 50 for CaM activation of O 2 . production was also altered. These observations are in good agreement with reports measuring NO output from the S1177D eNOS and from an eNOS in which the C-terminal 27 amino acids (containing Ser-1177) were deleted (⌬27) (21, 50) . Both the C-terminal region of eNOS and an autoinhibitory region located in the FMN binding domain regulate the flow of electrons within the reductase domain, modulate CaM activation, and are thought to act in concert to regulate NOS function (51) . Ser-1177 lies within the C-terminal region, and its phosphorylation is thought to regulate NO production from eNOS by altering the interaction between the C-terminal and autoinhibitory region (AR), releasing the AR-dependent inhibition. Along with the prior work using S1177D and ⌬27, our data support this hypothesis. However, although Ser-1177 phosphorylation enhances the eNOS-CaM interaction, this phosphorylation event also would lead to an increase in the absolute rate of electron transfer from the reductase domain to the heme with increased flavin reduction rate, a hallmark of AR inhibition release (47) .
Thr-495 lies within the CaM binding domain of eNOS, and the currently accepted dogma is that phosphorylation of eNOS at Thr-495 (human) or Thr-497 (bovine) inhibits NO production by interfering with CaM binding (27) . However, more recent studies have questioned this. It has been shown that treatment of BAECs with okadaic acid and PMA, which increased Thr-497 phosphorylation, enhanced NO production compared with control (44) . Moreover, although the T495A eNOS mutant, which mimics dephosphorylation, did increase NO production, mutagenesis of this residue to aspartic acid to mimic phosphorylation had no effect on eNOS NO activity (22) . The dephosphorylation of Thr-495 has been linked to increasing eNOS-dependent O 2 . generation in endothelial cells via the inhibition of PKC␣ (52) . Conversely it has been reported that PKC␣ overexpression activates eNOS and increases arterial blood flow in vivo (53) , but it was hypothesized that this occurred due to an increase in Ser-1177 phosphorylation, not phosphorylation or dephosphorylation of Thr-495. Our work demonstrated that phosphorylation of Thr-495 using PKC␣ did indeed greatly decrease CaM binding affinity; however, under conditions where CaM was saturating there was no effect on the maximal rate of O 2 . generation. Our cellular findings show strong heme-dependent O 2 . generation from BH 4 -depleted BAECs even with the phosphorylation of Thr-495, clearly demonstrating that Thr-495 phosphorylation is not strictly an "off-switch." It has been shown that the cellular concentration of CaM is greater than 10 M (54), which is higher than the saturating concentration of CaM used in our in vitro study. As such, although phosphorylation of Thr-495 does decrease CaM binding affinity for eNOS and thereby potentially leads to a decrease in eNOS activity, any potential negative regulation in cells would require alterations of other cellular factors that influence the eNOS-CaM interaction.
Previously it has been shown that the association of eNOS with caveolin inhibits eNOS activity (36, 37) . Our results showed that the caveolin-dependent inhibition of eNOS O 2 .
generation was enhanced by phosphorylation of eNOS, with the greatest inhibition seen when Thr-495 was phosphorylated. This indicates that phosphorylation of eNOS increases the association between eNOS and caveolin. As such, our in vitro data are consistent with the hypothesis that Thr-495 phosphorylation negatively regulates eNOS activity (13, 20, 22, 44, 52, 55, 56) . Previous reports have indicated that phosphorylation of eNOS at Ser-1177 leads to a dissociation of eNOS and caveolin; however, this dissociation was dependent upon the induction of caveolin-dependent endocytosis (57, 58) . We conclude that phosphorylation of heNOS at Thr-495 plays a role in the regulation of eNOS activity indirectly through the alteration of CaM binding and the association with caveolin. However, the precise in vivo regulation induced by Thr-495 phosphorylation will clearly be dependent upon processes that regulate local CaM and caveolin concentrations.
In the process of ischemia-reperfusion injury, the oxidative stress in tissues can lead to depletion of BH 4 (3, 4, 59 ). Recently OCTOBER 3, 2008 • VOLUME 283 • NUMBER 40
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at UNIV OF TEXAS AT DALLAS on May 29, 2009 www.jbc.org we have reported that hearts subjected to various durations of ischemia show a time-dependent decrease in BH 4 levels that trigger increased NOS-derived O 2 . production (60). Our current work demonstrates that with Akt-mediated phosphorylation, which would normally enhance eNOS-derived NO, increased eNOS-derived O 2 . production is also triggered from the uncoupled enzyme. Thus, when designing treatment strategies to ameliorate oxidative stress induced diseases by altering posttranslational modification of eNOS, one must consider that the activity of both coupled and uncoupled eNOS will be modified. For example, a strategy to enhance eNOS-derived NO by treatment with VEGF or other stimulus that induces Ser-1177 phosphorylation may exacerbate eNOS dysfunction in the post-ischemic heart. Moreover, although it was previously predicted that treatments to phosphorylate (61) . Additionally, ONOO Ϫ has been found to be a non-toxic signaling molecule, altering a number of cell signal transduction pathways (62) . Thus, with partial BH 4 depletion, differential phosphorylation of eNOS could modulate ONOO Ϫ generation, leading to altered cell signaling or cell death.
In conclusion, PKC␣-mediated phosphorylation of heNOS can decrease O 2 . production from the enzyme through alterations in its interactions with CaM and caveolin. Thus, Thr-495 phosphorylation indirectly regulates eNOS via modulation of protein-protein interactions. In contrast, Akt-mediated phosphorylation markedly enhances this O 2 . production directly by altering the kinetics of electron transfer within the enzyme. Additionally, this phosphorylation of Ser-1177 greatly increases O 2 . production at low levels of Ca 2ϩ such that eNOSdependent O 2 . generation becomes largely Ca 2ϩ -independent. Thus, phosphorylation is of key importance in regulating the overall function, activation, and potentially the coupling, of eNOS, modulating both the production of NO and O 2 . from the enzyme.
